Inadequate evaluation of potential side effects of sildenafil in preterm stopped Dutch trial.


Journal

The International journal of risk & safety in medicine
ISSN: 1878-6847
Titre abrégé: Int J Risk Saf Med
Pays: Netherlands
ID NLM: 9100907

Informations de publication

Date de publication:
2020
Historique:
pubmed: 5 5 2020
medline: 26 8 2021
entrez: 5 5 2020
Statut: ppublish

Résumé

Recently a drug trial in the Netherlands in which the efficacy of oral sildenafil was compared to placebo in women bearing children with fetal growth restriction was stopped early because of very harmful side effects to the babies. There were quite some unwanted and unscientific aspects related to this study and the manner in which the side effects were communicated to the patients and the community. These have not gained the attention they ought to have. We therefore made an analysis of the basic problems which aims to prevent that the trust in medical research will be weakened.

Identifiants

pubmed: 32364137
pii: JRS202003
doi: 10.3233/JRS-202003
doi:

Substances chimiques

Vasodilator Agents 0
Sildenafil Citrate BW9B0ZE037

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

145-148

Auteurs

Dick Bijl (D)

Physician-Epidemiologist, Utrecht, The Netherlands.

David Healy (D)

Professor of Psychiatry, Hergest Unit, Bangor, Wales, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH